Why the study?
Do SGLT-2 Inhibitors reduce Peripheral Artery Disease Risk in People With Type 2 Diabetes?
Do SGLT-2 Inhibitors reduce Peripheral Artery Disease Risk in People With Type 2 Diabetes?
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Giugliano et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: